Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Ischemic Heart Disease

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 210 articles: HTML format Text format

Single Articles

March 2010
1. ALEXOPOULOS D , Xanthopoulou I, Davlouros P, Damelou A, et al
   Mechanisms of nonfatal acute myocardial infarction late after stent implantation: The relative impact of disease progression, stent restenosis, and stent thrombosis.
   Am Heart J. 2010;159:439-445.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. OLOMU AB , Grzybowski M, Ramanath VS, Rogers AM, et al
   Evidence of disparity in the application of quality improvement efforts for the treatment of acute myocardial infarction: The American College of Cardiology's Guidelines Applied in Practice Initiative in Michigan.
   Am Heart J. 2010;159:377-384.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. TALJAARD M , Ward MR, Kutryk MJ, Courtman DW, et al
   Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction.
   Am Heart J. 2010;159:354-360.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. DEYELL MW , Ghali WA, Ross DB, Zhang J, et al
   Timing of nonemergent coronary artery bypass grafting and mortality after non-ST elevation acute coronary syndrome.
   Am Heart J. 2010;159:490-496.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. SCHENKEVELD L , Pedersen SS, van Nierop JW, Lenzen MJ, et al
   Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention.
   Am Heart J. 2010;159:471-476.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. PETERSEN JL , Barron JJ, Hammill BG, Cziraky MJ, et al
   Clopidogrel use and clinical events after drug-eluting stent implantation: Findings from the HealthCore Integrated Research Database.
   Am Heart J. 2010;159:462-470.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. FERENC M , Gick M, Kienzle RP, Bestehorn HP, et al
   Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents.
   Am Heart J. 2010;159:454-461.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. PARK KW , Kim CH, Lee HY, Kang HJ, et al
   Does "late catch-up" exist in drug-eluting stents: Insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents.
   Am Heart J. 2010;159:446-453.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. MOERENHOUT CM , Claeys MJ, Haine S, Miljoen H, et al
   Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: Experience with the point-of-care Platelet Function Assay-100 C/ADP.
   Am Heart J. 2010;159:434-438.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. RIEGEL B , Hanlon AL, McKinley S, Moser DK, et al
    Differences in mortality in acute coronary syndrome symptom clusters.
    Am Heart J. 2010;159:392-398.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. BROWN TM , Voeks JH, Bittner V, Safford MM, et al
    Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Am Heart J. 2010;159:385-391.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MEYER P , Gayda M, Normandin E, Guiraud T, et al
    "High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation: A randomized controlled trial evaluating the relationship to endothelial function and inflammation." Am Heart J 2009
    Am Heart J. 2010;159:e21.
    PubMed     Text format     Related articles   
    
    
    
13. GRANT WB
    Low vitamin D may explain the link between preeclampsia and cardiovascular disease.
    Am Heart J. 2010;159:e19.
    PubMed     Text format     Related articles   
    
    
    
14. ROGERS K
    Author response: B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Am Heart J. 2010;159:e17.
    PubMed     Text format     Related articles   
    
    
    
15. WIWANITKIT V
    Brain natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Am Heart J. 2010;159:e15.
    PubMed     Text format     Related articles   
    
    
    February 2010
16. MEISINGER C , Beck J, Heier M, Hormann A, et al
    Myocardial infarction and incidence of type 2 diabetes mellitus. Is admission blood glucose an independent predictor for future type 2 diabetes mellitus?
    Am Heart J. 2010;159:258-263.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. DAVIDSON KW , Mostofsky E
    Anger expression and risk of coronary heart disease: Evidence from the Nova Scotia Health Survey.
    Am Heart J. 2010;159:199-206.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. UNSWORTH B , Casula RP, Kyriacou AA, Yadav H, et al
    The right ventricular annular velocity reduction caused by coronary artery bypass graft surgery occurs at the moment of pericardial incision.
    Am Heart J. 2010;159:314-322.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. HLATKY MA , Chung SC, Escobedo J, Hillegass WB, et al
    The effect of obesity on quality of life in patients with diabetes and coronary artery disease.
    Am Heart J. 2010;159:292-300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. LEE SW , Park SW, Yun SC, Kim YH, et al
    Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
    Am Heart J. 2010;159:284-291.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. KIM JS , Hong MK, Fan C, Kim TH, et al
    Intracoronary thrombus formation after drug-eluting stents implantation: Optical coherence tomographic study.
    Am Heart J. 2010;159:278-283.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. KUBO T , Maehara A, Mintz GS, Garcia-Garcia HM, et al
    Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound.
    Am Heart J. 2010;159:271-277.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. PARIKH NI , Cnattingius S, Dickman PW, Mittleman MA, et al
    Parity and risk of later-life maternal cardiovascular disease.
    Am Heart J. 2010;159:215-221.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. XIAN Y , Pan W, Peterson ED, Heidenreich PA, et al
    Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals.
    Am Heart J. 2010;159:207-214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. SCHIELE F , Meneveau N, Seronde MF, Descotes-Genon V, et al
    Routine use of fondaparinux in acute coronary syndromes: A 2-year multicenter experience.
    Am Heart J. 2010;159:190-198.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. JOYAL D , Filion KB, Eisenberg MJ
    Effectiveness and safety of drug-eluting stents in vein grafts: A meta-analysis.
    Am Heart J. 2010;159:159-169.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. MANDAWAT A , Shah SJ, Rathore SS
    ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon time.
    Am Heart J. 2010;159:e1.
    PubMed     Text format     Related articles   
    
    
    
28. SOLOMON R
    Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
    Am Heart J. 2010;159:e7.
    PubMed     Text format     Related articles   
    
    
    January 2010
29. JARAI R , Huber K, Bogaerts K, Droogne W, et al
    Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment S
    Am Heart J. 2010;159:131-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. KOTOWYCZ MA , Cosman TL, Tartaglia C, Afzal R, et al
    Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).
    Am Heart J. 2010;159:117.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. HARKNESS JR , Sabatine MS, Braunwald E, Morrow DA, et al
    Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.
    Am Heart J. 2010;159:55-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. KRUSZEWSKI K , Scott AE, Barclay JL, Small GR, et al
    Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.
    Am Heart J. 2010;159:47-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. NUCIFORA G , Schuijf JD, Delgado V, Bertini M, et al
    Incremental value of subclinical left ventricular systolic dysfunction for the identification of patients with obstructive coronary artery disease.
    Am Heart J. 2010;159:148-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. MEHTA RH , Lopes RD, Ballotta A, Frigiola A, et al
    Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?
    Am Heart J. 2010;159:141-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. TIROCH KA , Matheny ME, Resnic FS
    Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization.
    Am Heart J. 2010;159:125-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. BEINART R , Abu Sham'a R, Segev A, Hod H, et al
    The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome.
    Am Heart J. 2010;159:118-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. WHITE HD , Aylward PE, Gallo R, Bode C, et al
    Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.
    Am Heart J. 2010;159:110-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. CAPODANNO D , Miano M, Cincotta G, Caggegi A, et al
    EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention.
    Am Heart J. 2010;159:103-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. ELBARASI E , Goodman SG, Yan RT, Welsh RC, et al
    Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.
    Am Heart J. 2010;159:40-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. ADABAG AS , Peterson G, Apple FS, Titus J, et al
    Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation.
    Am Heart J. 2010;159:33-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. MOSS AJ , Goldenberg I
    Prevention of sudden cardiac death: need for a plaque stabilizer.
    Am Heart J. 2010;159:15-6.
    PubMed     Text format     Related articles   
    
    
    December 2009
42. FIGUERAS J , Ferreira-Gonzalez I, Rizzo M, Alcalde O, et al
    High incidence of TIMI flow 0 to I in patients with ST-elevation myocardial infarction without electrocardiographic lytic criteria.
    Am Heart J. 2009;158:1011-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. BERGER JS , Roe MT, Gibson CM, Kilaru R, et al
    Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early
    Am Heart J. 2009;158:998-1004.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. MARGOLIS KL , Dunn K, Simpson LM, Ford CE, et al
    Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT).
    Am Heart J. 2009;158:948-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. TANG YD , Hasan F, Giordano FJ, Pfau S, et al
    Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.
    Am Heart J. 2009;158:941-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. MEADOWS TA , Bhatt DL, Hirsch AT, Creager MA, et al
    Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry.
    Am Heart J. 2009;158:1038-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. MOHOLDT TT , Amundsen BH, Rustad LA, Wahba A, et al
    Aerobic interval training versus continuous moderate exercise after coronary artery bypass surgery: a randomized study of cardiovascular effects and quality of life.
    Am Heart J. 2009;158:1031-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. MALUENDA G , Lemesle G, Collins SD, Ben-Dor I, et al
    The clinical significance of hematocrit values before and after percutaneous coronary intervention.
    Am Heart J. 2009;158:1024-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. HERMILLER JB , Fergus T, Pierson W, Su X, et al
    Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: a post hoc analysis of the SPIRIT III randomized trial.
    Am Heart J. 2009;158:1005-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. CID-ALVAREZ B , Gude F, Cadarso-Suarez C, Gonzalez-Babarro E, et al
    Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coronary syndrome: nonlinearity of hazard ratios and time-dependent comparison.
    Am Heart J. 2009;158:989-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. CAVENDER MA , Alexander KP, Broderick S, Shaw LK, et al
    Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease.
    Am Heart J. 2009;158:933-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. BANIHASHEMI B , Goodman SG, Yan RT, Welsh RC, et al
    Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
    Am Heart J. 2009;158:917-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. PERERA D , Stables R, Booth J, Thomas M, et al
    The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design.
    Am Heart J. 2009;158:910-916.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. CAMENZIND E , Wijns W, Mauri L, Boersma E, et al
    Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent im
    Am Heart J. 2009;158:902-909.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. SCHWARTZ GG , Olsson AG, Ballantyne CM, Barter PJ, et al
    Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.
    Am Heart J. 2009;158:896-901.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. RAO SV , Eikelboom J, Steg PG, Lincoff AM, et al
    Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group.
    Am Heart J. 2009;158:881-886.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
57. VOROBCSUK A , Konyi A, Aradi D, Horvath IG, et al
    Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction Systematic overview and meta-analysis.
    Am Heart J. 2009;158:814-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. EITEL I , Desch S, Sareban M, Fuernau G, et al
    Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty.
    Am Heart J. 2009;158:806-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. BRENER SJ , Westerhout CM, Fu Y, Todaro TG, et al
    Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Am Heart J. 2009;158:755-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. THOMAS D , Giugliano RP
    Management of ST-segment elevation myocardial infarction: Comparison of the updated guidelines from North America and Europe.
    Am Heart J. 2009;158:695-705.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. ROSENBLOOM JI , Wellenius GA, Mukamal KJ, Mittleman MA, et al
    Self-reported anxiety and the risk of clinical events and atherosclerotic progression among patients with Coronary Artery Bypass Grafts (CABG).
    Am Heart J. 2009;158:867-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. NG AC , Sitges M, Pham PN, Tran da T, et al
    Incremental value of 2-dimensional speckle tracking strain imaging to wall motion analysis for detection of coronary artery disease in patients undergoing dobutamine stress echocardiography.
    Am Heart J. 2009;158:836-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. LASKEY W , Aspelin P, Davidson C, Rudnick M, et al
    Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
    Am Heart J. 2009;158:822-828.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. AL-KHATIB SM , Hafley G, Harrington RA, Mack MJ, et al
    Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial.
    Am Heart J. 2009;158:792-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. SINGLA A , Antonino MJ, Bliden KP, Tantry US, et al
    The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy.
    Am Heart J. 2009;158:784.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. ROGERS RK , May HT, Anderson JL, Muhlestein JB, et al
    Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Am Heart J. 2009;158:777-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. AMSTERDAM EA , Peterson ED, Ou FS, Newby LK, et al
    Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative.
    Am Heart J. 2009;158:748-754.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. MUNK PS , Staal EM, Butt N, Isaksen K, et al
    High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation A randomized controlled trial evaluating the relationship to endothelial function and inflammation.
    Am Heart J. 2009;158:734-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. MELLONI C , Fier I, Roach J, Kosinski AS, et al
    Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trial.
    Am Heart J. 2009;158:726-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. DEWILDE W , Berg JT
    Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).
    Am Heart J. 2009;158:713-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
71. GEHRIE ER , Reynolds HR, Chen AY, Neelon BH, et al
    Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early
    Am Heart J. 2009;158:688-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. KATZ JN , Stebbins AL, Alexander JH, Reynolds HR, et al
    Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.
    Am Heart J. 2009;158:680-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. DAVLOUROS PA , Arseniou A, Hahalis G, Chiladakis J, et al
    Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies.
    Am Heart J. 2009;158:585-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. RAKOWSKI T , Siudak Z, Dziewierz A, Birkemeyer R, et al
    Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry.
    Am Heart J. 2009;158:569-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. MAHABADI AA , Bamberg F, Toepker M, Schlett CL, et al
    Association of aortic valve calcification to the presence, extent, and composition of coronary artery plaque burden: from the Rule Out Myocardial Infarction using Computer Assisted Tomography (ROMICAT) trial.
    Am Heart J. 2009;158:562-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. HEIDENREICH PA , Lewis WR, LaBresh KA, Schwamm LH, et al
    Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure.
    Am Heart J. 2009;158:546-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. DI LORENZO E , Sauro R, Varricchio A, Capasso M, et al
    Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.
    Am Heart J. 2009;158:e43-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. HSIEH BP , Rogers AM, Na B, Wu AH, et al
    Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study.
    Am Heart J. 2009;158:673-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. KO DT , Chiu M, Guo H, Austin PC, et al
    Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents.
    Am Heart J. 2009;158:592-598.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. AUSTIN D , Oldroyd KG, Holmes DR Jr, Rihal CS, et al
    Drug-eluting stents: a study of international practice.
    Am Heart J. 2009;158:576-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. BUDOFF MJ , McClelland RL, Nasir K, Greenland P, et al
    Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Am Heart J. 2009;158:554-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. NIKOLSKY E , Lansky AJ, Sudhir K, Doostzadeh J, et al
    SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
    Am Heart J. 2009;158:520-526.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. ZHAO SP , Peng DQ, Yu BL, Huo Y, et al
    Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Am Heart J. 2009;158:509-512.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. MUKHERJEE D
    The high cost of nonadherence after percutaneous coronary intervention--can health care reform solve this problem?
    Am Heart J. 2009;158:506-8.
    PubMed     Text format     Related articles   
    
    
    
85. KOSTER R , Kaehler J, Meinertz T
    Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
    Am Heart J. 2009;158:e51-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. SHISHEHBOR MH , Hawi R, Singh IM, Tuzcu EM, et al
    Drug-eluting versus bare-metal stents for treating saphenous vein grafts.
    Am Heart J. 2009;158:637-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. LAUKKANEN JA , Makikallio TH, Kauhanen J, Kurl S, et al
    Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death.
    Am Heart J. 2009;158:615-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. KLOMP M , Beijk MA, Verouden NJ, Tijssen JG, et al
    Design and rationale of the TRI-stent adjudication study (TRIAS) program.
    Am Heart J. 2009;158:527-532.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. CANNON CP , Dansky HM, Davidson M, Gotto AM Jr, et al
    Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.
    Am Heart J. 2009;158:513-519.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. THOMBS BD , Jewett LR, Knafo R, Coyne JC, et al
    Learning from history: a commentary on the American Heart Association Science Advisory on depression screening.
    Am Heart J. 2009;158:503-5.
    PubMed     Text format     Related articles   
    
    
    
91. CORTESE B , Picchi A, Micheli A, Limbruno U, et al
    Are we sure we have taken the best from clopidogrel?
    Am Heart J. 2009;158:e59.
    PubMed     Text format     Related articles   
    
    
    September 2009
92. GHEORGHIADE M , Khan S, Blair JE, Harinstein ME, et al
    The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.
    Am Heart J. 2009;158:437-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. DE LUCA G , Gibson CM, Huber K, Zeymer U, et al
    Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors.
    Am Heart J. 2009;158:416-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. BLANKENSHIP JC , Skelding KA, Scott TD, Buckley J, et al
    ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon time.
    Am Heart J. 2009;158:400-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. WILSON SR , Sabatine MS, Braunwald E, Sloan S, et al
    Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
    Am Heart J. 2009;158:386-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. TRAVERSE JH , Henry TD, Vaughn DE, Ellis SG, et al
    Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
    Am Heart J. 2009;158:356-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. LOZANO I , Rondan J, Avanzas P
    Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?
    Am Heart J. 2009;158:e39.
    PubMed     Text format     Related articles   
    
    
    
98. PRIDE YB , Wiviott SD, Buros JL, Zorkun C, et al
    Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibiti
    Am Heart J. 2009;158:e21-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. DE JONG JS , Marsman RF, Henriques JP, Koch KT, et al
    Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
    Am Heart J. 2009;158:467-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. BULLER CE , Rankin JM, Carere RG, Buszman PE, et al
     Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.
     Am Heart J. 2009;158:408-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. ELBAROUNI B , Goodman SG, Yan RT, Welsh RC, et al
     Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada.
     Am Heart J. 2009;158:392-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. HERMAN M , Donovan J, Tran M, McKenna B, et al
     Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target?
     Am Heart J. 2009;158:378-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. CHOW CK , Joshi R, Gottumukkala AK, Raju K, et al
     Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India.
     Am Heart J. 2009;158:349-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. 
     The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale.
     Am Heart J. 2009;158:327-334.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. JOFFE SW , Ferrara J, Chalian A, Tighe DA, et al
     Are ejection fraction measurements by echocardiography and left ventriculography equivalent?
     Am Heart J. 2009;158:496-502.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. KORENFELD Y , Mendoza-Bastidas C, Saavedra L, Montero-Gomez A, et al
     Current status of cardiac rehabilitation in Latin America and the Caribbean.
     Am Heart J. 2009;158:480-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. PASQUALI SK , Marino BS, Pudusseri A, Wernovsky G, et al
     Risk factors and comorbidities associated with obesity in children and adolescents after the arterial switch operation and Ross procedure.
     Am Heart J. 2009;158:473-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. FARQUHAR H , Weatherall M, Wijesinghe M, Perrin K, et al
     Systematic review of studies of the effect of hyperoxia on coronary blood flow.
     Am Heart J. 2009;158:371-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2009
109. LEIBUNDGUT G , Nietlispach F, Pittl U, Brunner-La Rocca H, et al
     Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina--comparison of the effects of drug-eluting versus bare-metal stents.
     Am Heart J. 2009;158:271-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. COHEN MG , Filby SJ, Roe MT, Chen AY, et al
     The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guideline
     Am Heart J. 2009;158:263-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. ASKARI AT , Shishehbor MH, Kaminski MA, Riley MJ, et al
     The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from global use of strategies to open coronary arteries (GUSTO) V.
     Am Heart J. 2009;158:238-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. JOFFE SW , Chalian A, Tighe DA, Aurigemma GP, et al
     Trends in the use of echocardiography and left ventriculography to assess left ventricular ejection fraction in patients hospitalized with acute myocardial infarction.
     Am Heart J. 2009;158:185-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. RAZZOUK L , Muntner P, Bansilal S, Kini AS, et al
     C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
     Am Heart J. 2009;158:277-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. GIBSON PH , Croal BL, Cuthbertson BH, Rae D, et al
     Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting: a prospective comparative study.
     Am Heart J. 2009;158:244-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. FLU WJ , van Kuijk JP, Hoeks SE, Kuiper R, et al
     Intima media thickness of the common carotid artery in vascular surgery patients: A predictor of postoperative cardiovascular events.
     Am Heart J. 2009;158:202-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. GOODMAN SG , Huang W, Yan AT, Budaj A, et al
     The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes.
     Am Heart J. 2009;158:193-201.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. RUISI CP , Goldberg RJ, Kennelly BM, Goodman SG, et al
     Pulmonary artery catheterization in patients with acute coronary syndromes.
     Am Heart J. 2009;158:170-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. GONZALO N , Serruys PW, Okamura T, van Beusekom HM, et al
     Optical coherence tomography patterns of stent restenosis.
     Am Heart J. 2009;158:284-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. DROUET L , Bal dit Sollier C, Martin J
     Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study.
     Am Heart J. 2009;158:177-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2009
120. VAN DER NET JB , Janssens AC, Sijbrands EJ, Steyerberg EW, et al
     Value of genetic profiling for the prediction of coronary heart disease.
     Am Heart J. 2009;158:105-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. APPELBAUM E , Abraham JM, Pride YB, Harrigan CJ, et al
     Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
     Am Heart J. 2009;158:84-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. ANG DS , Kong CF, Kao MP, Struthers AD, et al
     Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
     Am Heart J. 2009;158:133-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. HERNANDEZ AF , Li S, Dokholyan RS, O'Brien SM, et al
     Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons.
     Am Heart J. 2009;158:47-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. DUMAINE RL , Montalescot G, Steg PG, Ohman EM, et al
     Renal function, atherothrombosis extent, and outcomes in high-risk patients.
     Am Heart J. 2009;158:141-148.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. YAMAMOTO M , Okamatsu K, Inami S, Takano M, et al
     Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
     Am Heart J. 2009;158:99-104.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. OTA T , Umeda H, Yokota S, Miyata S, et al
     Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
     Am Heart J. 2009;158:92-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. SELLENG S , Greinacher A, Ittermann T, Wollert HG, et al
     Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
     Am Heart J. 2009;158:e15.
     PubMed     Text format     Related articles   
     
     
     June 2009
128. WEIR RA , Mark PB, Petrie CJ, Clements S, et al
     Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?
     Am Heart J. 2009;157:1088-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. OSHEROV AB , Borovik-Raz M, Aronson D, Agmon Y, et al
     Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era.
     Am Heart J. 2009;157:1074-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. PIEPER KS , Gore JM, FitzGerald G, Granger CB, et al
     Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events.
     Am Heart J. 2009;157:1097-105.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. YOON MH , Tahk SJ, Yang HM, Park JS, et al
     Comparison of the intracoronary continuous infusion method using a microcatheter and the intravenous continuous adenosine infusion method for inducing maximal hyperemia for fractional flow reserve measurement.
     Am Heart J. 2009;157:1050-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. ARNOLD SV , Spertus JA, Jones PG, Xiao L, et al
     The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry.
     Am Heart J. 2009;157:1042-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. FLAHERTY JD , Rossi JS, Fonarow GC, Nunez E, et al
     Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
     Am Heart J. 2009;157:1018-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. PATEL MJ , de Lemos JA, McGuire DK, See R, et al
     Evaluation of coronary artery calcium screening strategies focused on risk categories: the Dallas Heart Study.
     Am Heart J. 2009;157:1001-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. FORMAN DE , Cannon CP, Hernandez AF, Liang L, et al
     Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF).
     Am Heart J. 2009;157:1010-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. FISCELLA K , Tancredi D, Franks P
     Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment.
     Am Heart J. 2009;157:988-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2009
137. BONELLO L , De Labriolle A, Lemesle G, Steinberg DH, et al
     Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions.
     Am Heart J. 2009;157:894-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. NUCIFORA G , Marsan NA, Holman ER, Siebelink HM, et al
     Real-time 3-dimensional echocardiography early after acute myocardial infarction: incremental value of echo-contrast for assessment of left ventricular function.
     Am Heart J. 2009;157:882.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. KOVACIC JC , Macdonald P, Feneley MP, Graham RM, et al
     Granulocyte-colony stimulating factor in refractory ischemic heart disease: throwing stones from glass houses.
     Am Heart J. 2009;157:e39.
     PubMed     Text format     Related articles   
     
     
     
140. THOMBS BD , Adeponle AB, Kirmayer LJ, Rousseau C, et al
     More antidepressants for African Americans with coronary heart disease? Maybe--maybe not.
     Am Heart J. 2009;157:e33.
     PubMed     Text format     Related articles   
     
     
     
141. LEE KK , Fortmann SP, Fair JM, Iribarren C, et al
     Insulin resistance independently predicts the progression of coronary artery calcification.
     Am Heart J. 2009;157:939-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. VAN KUIJK JP , Dunkelgrun M, Schreiner F, Flu WJ, et al
     Preoperative oral glucose tolerance testing in vascular surgery patients: long-term cardiovascular outcome.
     Am Heart J. 2009;157:919-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. SUH JW , Baek SH, Park JS, Kang HJ, et al
     Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study.
     Am Heart J. 2009;157:908-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. BUTLER MJ , Eccleston D, Clark DJ, Ajani AE, et al
     The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.
     Am Heart J. 2009;157:899-907.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. CUISSET T , Frere C, Quilici J, Gaborit B, et al
     Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting.
     Am Heart J. 2009;157:889-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. SCULPHER MJ , Lozano-Ortega G, Sambrook J, Palmer S, et al
     Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
     Am Heart J. 2009;157:845-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. PRICE MJ , Berger PB, Angiolillo DJ, Teirstein PS, et al
     Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.
     Am Heart J. 2009;157:818-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. SAKHUJA R , Bhatt DL
     Getting real with drug-eluting stents: 5-year follow up of a real-world cohort.
     Am Heart J. 2009;157:802-4.
     PubMed     Text format     Related articles   
     
     
     
149. DIB C , Asirvatham S, Elesber A, Rihal C, et al
     Clinical correlates and prognostic significance of electrocardiographic abnormalities in apical ballooning syndrome (Takotsubo/stress-induced cardiomyopathy).
     Am Heart J. 2009;157:933-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. ADABAG AS , Mithani S, Al Aloul B, Collins D, et al
     Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial.
     Am Heart J. 2009;157:913-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. GOY JJ , Urban P, Kaufmann U, Seydoux C, et al
     Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice.
     Am Heart J. 2009;157:883-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. MARK DB , Knight JD, Velazquez EJ, Howlett JG, et al
     Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial.
     Am Heart J. 2009;157:837-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. PARK KW , Yoon JH, Kim JS, Hahn JY, et al
     Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: study design and rationale of a Korean multicenter prospective randomized trial.
     Am Heart J. 2009;157:811-817.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. ALLEN LA , Granger CB
     Risk assessment in the genomic era: are we missing the low-hanging fruit?
     Am Heart J. 2009;157:799-801.
     PubMed     Text format     Related articles   
     
     
     
155. COYNE JC , de Jonge P
     Should African Americans be overtreated for depression the same as whites are? Commentary on Waldman et al (2009).
     Am Heart J. 2009;157:e31.
     PubMed     Text format     Related articles   
     
     
     April 2009
156. GOYAL A , Mehta SR, Gerstein HC, Diaz R, et al
     Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.
     Am Heart J. 2009;157:763-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. MALEK LA , Reynolds HR, Forman SA, Vozzi C, et al
     Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT).
     Am Heart J. 2009;157:724-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. NIU S , Zhao D, Zhu J, Liu J, et al
     The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary
     Am Heart J. 2009;157:709-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. LAMBERT ND , Sacrinty MT, Ketch TR, Turner SJ, et al
     Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
     Am Heart J. 2009;157:688-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. BEYGUI F , Montalescot G, Vicaut E, Rouanet S, et al
     Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitaliere, l'Evolution a un an et les caRacteristiques de patients presentant un infArctus du myocarde avec ou sans
     Am Heart J. 2009;157:680-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. TRUONG QA , Cannon CP, Zakai NA, Rogers IS, et al
     Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial.
     Am Heart J. 2009;157:673-679.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. CANTOR WJ , Baptista SB, Srinivas VS, Pearte CA, et al
     Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial.
     Am Heart J. 2009;157:666-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. VASILE VC , Babuin L, Ting HH, Bell MR, et al
     Aborted myocardial infarction: is it real in the troponin era?
     Am Heart J. 2009;157:636-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. TIZON-MARCOS H , Bertrand OF, Rodes-Cabau J, Larose E, et al
     Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes.
     Am Heart J. 2009;157:740-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. HAN Y , Li Y, Wang S, Jing Q, et al
     Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study.
     Am Heart J. 2009;157:733-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. WANG TY , Zhang M, Fu Y, Armstrong PW, et al
     Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.
     Am Heart J. 2009;157:716-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. SIONTIS GC , Tatsioni A, Katritsis DG, Ioannidis JP, et al
     Persistent reservations against contradicted percutaneous coronary intervention indications: citation content analysis.
     Am Heart J. 2009;157:695-701.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. MAK KH , Bhatt DL, Shao M, Hankey GJ, et al
     Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study.
     Am Heart J. 2009;157:658-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. RAO RV , Goodman SG, Yan RT, Spencer FA, et al
     Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes.
     Am Heart J. 2009;157:642-650.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. BYRNE RA , Schulz S, Mehilli J, Iijima R, et al
     Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual
     Am Heart J. 2009;157:620-624.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. SHRANK WH , Choudhry NK, Solomon DH, Snedden TM, et al
     Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.
     Am Heart J. 2009;157:613-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. BECKER MC , Wang TH, Wisniewski L, Wolski K, et al
     Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
     Am Heart J. 2009;157:606-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. JAMES S , Akerblom A, Cannon CP, Emanuelsson H, et al
     Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
     Am Heart J. 2009;157:599-605.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. HAGE FG , Heo J, Franks B, Belardinelli L, et al
     Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.
     Am Heart J. 2009;157:771-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. CRESPO EM , Oliveira GB, Honeycutt EF, Becker RC, et al
     Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry.
     Am Heart J. 2009;157:651-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. FRENCH JK , Shearer JA
     Are we letting good stories obscure the truth-Can qualitative techniques provide clarification?
     Am Heart J. 2009;157:597-8.
     PubMed     Text format     Related articles   
     
     
     
177. RATNAYAKE WM
     Letter to the editor.
     Am Heart J. 2009;157:e23.
     PubMed     Text format     Related articles   
     
     
     March 2009
178. LIPIECKI J , Monzy S, Durel N, Cachin F, et al
     Effect of thrombus aspiration on infarct size and left ventricular function in high-risk patients with acute myocardial infarction treated by percutaneous coronary intervention. Results of a prospective controlled pilot study.
     Am Heart J. 2009;157:583.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. LETTIERI C , Savonitto S, De Servi S, Guagliumi G, et al
     Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome.
     Am Heart J. 2009;157:569-575.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. DECKER C , Ahmad H, Moreng KL, Maddox TM, et al
     Risk factor management after myocardial infarction: reported adherence and outcomes.
     Am Heart J. 2009;157:556-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. DILL T , Schachinger V, Rolf A, Mollmann S, et al
     Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor ce
     Am Heart J. 2009;157:541-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. BANGALORE S , Messerli FH, Ou FS, Tamis-Holland J, et al
     Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American
     Am Heart J. 2009;157:525-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. GIRALDEZ RR , Sabatine MS, Morrow DA, Mohanavelu S, et al
     Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.
     Am Heart J. 2009;157:517-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. MUKAMAL KJ , Hallqvist J, Hammar N, Ljung R, et al
     Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program.
     Am Heart J. 2009;157:495-501.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. HAMMER-HANSEN S , Kofoed KF, Kelbaek H, Kristensen T, et al
     Volumetric evaluation of coronary plaque in patients presenting with acute myocardial infarction or stable angina pectoris-a multislice computerized tomography study.
     Am Heart J. 2009;157:481-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. LIANG CD , Kuo HC, Yang KD, Wang CL, et al
     Coronary artery fistula associated with Kawasaki disease.
     Am Heart J. 2009;157:584-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. JO SH , Koo BK, Park JS, Kang HJ, et al
     N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
     Am Heart J. 2009;157:576-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. BITTNER V , Johnson BD, Zineh I, Rogers WJ, et al
     The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE).
     Am Heart J. 2009;157:548-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. BI Y , Gao R, Patel A, Su S, et al
     Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
     Am Heart J. 2009;157:509-516.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. JOYNER CD , Peters RJ, Afzal R, Chrolavicius S, et al
     Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk.
     Am Heart J. 2009;157:502-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. WAN Q , Harris MF, Zwar N, Campbell T, et al
     Study protocol for a randomized controlled trial: The feasibility and impact of cardiovascular absolute risk assessment in Australian general practice.
     Am Heart J. 2009;157:436-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. BRENER SJ , Bhatt DL
     The pain and the gain of treating patients with acute coronary syndromes-can the two be separated?
     Am Heart J. 2009;157:399-401.
     PubMed     Text format     Related articles   
     
     
     
193. MATTIOLI AV , Bonetti L, Zennaro M, Ambrosio G, et al
     Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
     Am Heart J. 2009;157:589-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. VAN DEN BERGH PJ , Kievit PC, Brouwer MA, Aengevaeren WR, et al
     Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
     Am Heart J. 2009;157:532-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. FAXON DP , Freedman JE
     Facts and controversies of aspirin and clopidogrel therapy.
     Am Heart J. 2009;157:412-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
196. JENSEN MK , Rimm EB, Rader D, Schmidt EB, et al
     S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies.
     Am Heart J. 2009;157:384-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. SCHIELE F , Meneveau N, Chopard R, Descotes-Genon V, et al
     Prognostic value of albuminuria on 1-month mortality in acute myocardial infarction.
     Am Heart J. 2009;157:327-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. LEMESLE G , Delhaye C, Sudre A, Broucqsault D, et al
     Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.
     Am Heart J. 2009;157:375-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. ARONOW HD , Steinhubl SR, Brennan DM, Berger PB, et al
     Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
     Am Heart J. 2009;157:369-74.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. CESARI M , Kritchevsky SB, Atkinson HH, Penninx BW, et al
     Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.
     Am Heart J. 2009;157:334.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. EAGLE KA
     Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC).
     Am Heart J. 2009;157:319-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. ANYFANTAKIS ZA , Baron G, Aubry P, Himbert D, et al
     Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest.
     Am Heart J. 2009;157:312-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. ROFFI M , Mukherjee D
     Current role of emboli protection devices in percutaneous coronary and vascular interventions.
     Am Heart J. 2009;157:263-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
204. SHAH R
     Protease-activated receptors in cardiovascular health and diseases.
     Am Heart J. 2009;157:253-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. MOMMERSTEEG PM , Denollet J, Spertus JA, Pedersen SS, et al
     Health status as a risk factor in cardiovascular disease: a systematic review of current evidence.
     Am Heart J. 2009;157:208-18.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. FINN AV , Oh JS, Hendricks M, Daher M, et al
     Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo.
     Am Heart J. 2009;157:383.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. TSAKOK AD
     On coronary analyses.
     Am Heart J. 2009;157:e1.
     PubMed     Text format     Related articles   
     
     
     January 2009
208. BROWN J , Jenkins C, Marwick TH
     Use of myocardial strain to assess global left ventricular function: a comparison with cardiac magnetic resonance and 3-dimensional echocardiography.
     Am Heart J. 2009;157:102.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. ILIAS NA , Xian H, Inman C, Martin WH 3rd, et al
     Arm exercise testing predicts clinical outcome.
     Am Heart J. 2009;157:69-76.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
210. JAFFERY Z , Nowak R, Khoury N, Tokarski G, et al
     Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency department.
     Am Heart J. 2008;156:939-45.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: